1. |
中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识. 中国实用外科杂志, 2015, 35(7): 731-736.0.
|
2. |
Gunasekaran S, Wallace H, Snowden C, et al. Parathyroid ectopia: development of a surgical algorithm based on operative findings. J Laryngol Otol, 2015, 129(11): 1115-1120.
|
3. |
Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid glands. Surgery, 1984, 95(1): 14-21.
|
4. |
Arnault V, Beaulieu A, Lifante JC, et al. Multicenter study of 19 aortopulmonary window parathyroid tumors: the challenge of embryologic origin. World J Surg, 2010, 34(9): 2211-2216.
|
5. |
Chan TJ, Libutti SK, McCart JA, et al. Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures. World J Surg, 2003, 27(6): 675-679.
|
6. |
Lappas D, Noussios G, Anagnostis P, et al. Location, number and morphology of parathyroid glands: results from a large anatomical series. Anat Sci Int, 2012, 87(3): 160-164.
|
7. |
Pawlik TM, Richards M, Giordano TJ, et al. Identification and management of intravagal parathyroid adenoma. World J Surg, 2001, 25(4): 419-423.
|
8. |
李征. 99mTc-MIBI SPECT-CT 显像在纵隔内异位甲状旁腺诊治中的应用价值. 检验医学与临床, 2015, 12(6): 765-767.0.
|
9. |
管珩, 李沛, 朱预, 等. 异位甲状旁腺功能亢进症的外科治疗—66 例报告. 中华普通外科杂志, 2014, 29(6): 455-459.0.
|
10. |
Abu Abeeleh M, Bani Hani A, Ghaith A, et al. Aortopulmonary ectopic parathyroid gland and concurrent thymolipoma. Asian Cardiovasc Thorac Ann, 2016, 24(8): 822-824.
|
11. |
Siddiqi MS, Al Badai Y, Al Kemyani NA, et al. Combined transcervical and thoracoscopic mediastinal parathyroid adenoma resection. Asian Cardiovasc Thorac Ann, 2016, 24(6): 593-596.
|
12. |
Yeh MW, Wiseman JE, Chu SD, et al. Population-level predictors of persistent hyperparathyroidism. Surgery, 2011, 150(6): 1113-1119.
|
13. |
Venkat R, Kouniavsky G, Tufano RP, et al. Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy. World J Surg, 2012, 36(1): 55-60.
|
14. |
Nawrot I, Chudziński W, Ciąćka T, et al. Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit, 2014, 20: 1604-1612.
|
15. |
Henry JF. Reoperation for primary hyperparathyroidism: tips and tricks. Langenbecks Arch Surg, 2010, 395(2): 103-109.
|
16. |
Mehta A, Patel D, Rosenberg A, et al. Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery, 2014, 156(6): 1315-1325.
|
17. |
Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg, 2005, 140(5): 472-479.
|
18. |
Wang TS, Udelsman R. Remedial surgery for primary hyperparathyroidism. Adv Surg, 2007, 41: 1-15.
|
19. |
Cetani F, Pardi E, Marcocci C. Update on parathyroid carcinoma. J Endocrinol Invest, 2016, 39(6): 595-606.
|
20. |
Aloia JF. Clinical review: The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab, 2011, 96(10): 2987-2996.
|
21. |
Titon I, Cailleux-Bounacer A, Basuyau JP, et al. Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism. Eur J Endocrinol. 2007, 157(3): 351-357.
|
22. |
Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab, 2014, 99(10): 3561-3569.
|
23. |
Lowell AJ, Bushman NM, Wang X, et al. Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism. J Surg Res, 2017, 217: 252-257.
|
24. |
Kasperk C. Hypercalcemic crisis and hypocalcemic tetany. Internist (Berl), 2017 Aug 23. doi: 10.1007/s00108-017-0311-3. [Epub ahead of print].
|
25. |
Yokomoto M, Minamoto M, Utsunomiya D, et al. Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves' disease. Intern Med, 2015, 54(7): 813-818.
|
26. |
Singh DN, Gupta SK, Kumari N, et al. Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience. Indian J Endocrinol Metab, 2015, 19(1): 100-105.
|
27. |
Chen K, Xie Y, Zhao L, et al. Hyperthyroidism-associated hypercalcemic crisis: A case report and review of the literature. Medicine (Baltimore), 2017, 96(4): e6017.
|
28. |
Gradwohl-Matis I, Franzen M, Seelmaier C, et al. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis. ASAIO J, 2015, 61(2): 219-223.
|
29. |
Ahmad S, Kuraganti G, Steenkamp D. Hypercalcemic crisis: a clinical review. Am J Med, 2015, 128(3): 239-245.
|
30. |
Zhao L, Liu JM, He XY, et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab, 2013, 98(2): 721-728.
|
31. |
Jung KY, Hong AR, Lee DH, et al. The natural history and hip geometric changes of primary hyperparathyroidism without parathyroid surgery. J Bone Miner Metab, 2017, 35(3): 278-288.
|
32. |
Cansu GB, Yılmaz N, Özdem S, et al. Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness. Clin Endocrinol (Oxf), 2016, 84(1): 39-47.
|
33. |
Calò PG, Pisano G, Loi G, et al. Surgery for primary hyperparathyroidism in patients with preoperatively negative sestamibi scan and discordant imaging studies: the usefulness of intraoperative parathyroid hormone monitoring. Clin Med Insights Endocrinol Diabetes, 2013, 6: 63-67.
|
34. |
Boi F, Lombardo C, Cocco MC, et al. Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA-PTH assay. Eur J Endocrinol, 2012, 168(1): 49-58.
|
35. |
Elaraj DM, Sippel RS, Lindsay S, et al. Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg, 2010, 145(6): 578-581.
|
36. |
Richards ML, Thompson GB, Farley DR, et al. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring. Am J Surg, 2008, 196(6): 937-9423.
|
37. |
Yen TW, Wang TS, Doffek KM, et al. Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery, 2008, 144(4): 611-621.
|
38. |
Rajaei MH, Oltmann SC, Schneider DF, et al. Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant. Ann Surg Oncol, 2015, 22(3): 966-971.
|
39. |
Jäger MD, Emmanouilidis N, Jackobs S, et al. Presence of small parathyroid glands in renal transplant patients supports less-than-total parathyroidectomy to treat hypercalcemic hyperparathyroidism. Surgery, 2014, 155(1): 22-32.
|
40. |
邓先兆, 伍波, 钟春林, 等. 原发性甲状旁腺功能亢进的多学科联合诊治 120 例. 上海医学, 2012, 35(11): 931-934.0.
|